RVLP - RVL Pharmaceuticals plc GAAP EPS of -$0.24 misses by $0.12 revenue of $8.26M misses by $1.99M
2023-08-14 06:54:42 ET
- RVL Pharmaceuticals plc press release ( NASDAQ: RVLP ): Q2 GAAP EPS of -$0.24 misses by $0.12 .
- Revenue of $8.26M (-2.2% Y/Y) misses by $1.99M .
- At June 30, 2023, the Company had cash and cash equivalents of $19.2 million and senior secured indebtedness with aggregate principal maturities of $70.7 million.
For further details see:
RVL Pharmaceuticals plc GAAP EPS of -$0.24 misses by $0.12, revenue of $8.26M misses by $1.99M